Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine

被引：238

作者：

Stumpf, Julian ^{[1
,40
]}

Siepmann, Torsten ^{[2
]}

Lindner, Tom ^{[3
]}

Karger, Claudia ^{[4
]}

Schwoebel, Joerg ^{[5
]}

Anders, Leona ^{[6
]}

Faulhaber-Walter, Robert ^{[7
]}

Schewe, Jens ^{[8
]}

Martin, Heike ^{[9
]}

Schirutschke, Holger ^{[10
]}

Barnett, Kerstin ^{[11
]}

Huether, Jan ^{[12
]}

Mueller, Petra ^{[13
]}

Langer, Torsten ^{[14
]}

Pluntke, Thilo ^{[15
]}

Anding-Rost, Kirsten ^{[16
]}

Meistring, Frank ^{[17
]}

Stehr, Thomas ^{[18
]}

Pietzonka, Annegret ^{[19
]}

Escher, Katja ^{[20
]}

Cerny, Simon ^{[21
]}

Rothe, Hansjorg ^{[22
]}

Pistrosch, Frank ^{[23
]}

Seidel, Harald ^{[24
]}

Paliege, Alexander ^{[1
]}

Beige, Joachim ^{[4
,25
]}

Bast, Ingolf ^{[6
]}

Steglich, Anne ^{[1
]}

Gembardt, Florian ^{[1
]}

Kessel, Friederike ^{[1
]}

Kroeger, Hannah ^{[1
]}

Arndt, Patrick ^{[1
]}

Sradnick, Jan ^{[1
]}

Frank, Kerstin ^{[26
]}

Klimova, Anna ^{[27
]}

Mauer, Rene ^{[28
]}

Graehlert, Xina ^{[29
]}

Anft, Moritz ^{[30
,31
]}

Blazquez-Navarro, Arturo ^{[30
,31
]}

Westhoff, Timm H. ^{[32
]}

Stervbo, Ulrik ^{[30
,31
]}

Tonn, Torsten ^{[33
,34
]}

Babel, Nina ^{[30
,31
,35
,36
,37
,38
,39
]}

Hugo, Christian ^{[1
,40
]}

机构：

[1] Tech Univ Dresden, Univ Klinikum Carl Gustav Carus, Med Klin & Poliklin 3, Dresden, Germany

[2] Krankenhaus Kuhwald, KfH Nierenzentrum, Klinikum Chemnitz, Dresden, Germany

[3] Univ Hosp Leipzig, Div Nephrol, Leipzig, Germany

[4] Klinikum St Georg, KfH Nierenzentrum, Leipzig, Germany

[5] Dialysezenturm Chemnitz, Chemnitz, Germany

[6] Dialysepraxis Leipzig, Leipzig, Germany

[7] Nephrol Zentrum Freiberg, Freiberg, Germany

[8] Dialyse & Nierenambulanz Sebnitz, Sebnitz, Germany

[9] Nephrol Zentrum Zwickau, Zwickau, Germany

[10] PHV Dialysezentrum Dresden Friedrichstadt, Dresden, Germany

[11] Dialyse Heidenau, Heidenau, Germany

[12] Nephrocare GmbH Dobeln, Dobeln, Germany

[13] PHV Dialysezentrum Dresden Johannstadt, Dresden, Germany

[14] Dialysezentrum Annaberg, Annaberg Buchholz, Germany

[15] KfH Nierenzentrum Grimma, Grimma, Germany

[16] KfH Nierenzentrum Bischofswerda, Bischofswerda, Germany

[17] Stadt Klinikum Gorlitz, KfH Nierenzentrum, Gorlitz, Germany

[18] KfH Nierenzentrum Bautzen, Bautzen, Germany

[19] Via Medis Nierenzentrum Dresden MVZ GmbH, Dresden, Germany

[20] KfH Gesundheitszentrum Aue, Aue Bad Schlema, Germany

[21] ELBLAND Dialyse Grossenhain, Grossenhain, Germany

[22] Dialyse Praxis Weiwasser, Weiwasser, Germany

[23] Nephrol Zentrum Hoyerswerda, Hoyerswerda, Germany

[24] Vogtland Krankenhaus Plauen, KfH Nierenzentrum, Plauen, Germany

[25] Martin Luther Univ Halle Wittenberg, Dept Nephrol & Rheumatol, Internal Med 2, Halle, Germany

[26] DRK Blutspendedienst Nord Ost Gemeinnutzige GmbH, Inst Transfus Med Plauen, Plauen, Germany

[27] Natl Ctr Tumor Dis NCT, Partner Site Dresden, Dresden, Germany

[28] Tech Univ, Fac Med Carl Gustav Carus, Inst Med Informat & Biometry IMB, Dresden, Germany

[29] Coordinating Ctr Clin Trials, Dresden, Germany

[30] Ruhr Univ Bochum, Ctr Translat Med, Med Dept 1, Marien Hosp Herne,Univ Hosp, Bochum, Germany

[31] Ruhr Univ Bochum, Univ Hosp, Marien Hosp Herne, Med Dept 1,Immune Diagnost Lab, Bochum, Germany

[32] Ruhr Univ Bochum, Marien Hosp Herne, Med Dept 1, Univ Hosp, Herne, Germany

[33] German Red Cross Blood Donat Serv North East, Inst Transfus Med, Dresden, Germany

[34] Tech Univ, Fac Med Carl Gustav Carus, Transfus Med, Dresden, Germany

[35] Charite Univ Med Berlin, Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany

[36] Free Univ Berlin, Berlin, Germany

[37] Humboldt Univ, Berlin, Germany

[38] Berlin Inst Hlth, Berlin, Germany

[39] Inst Med Immunol, Berlin, Germany

[40] KfH Nierenzentrum Dresden, Dresden, Germany

来源：

LANCET REGIONAL HEALTH-EUROPE | 2021年 / 9卷

关键词：

epidemiology; COVID-19; SARS-CoV-2; vaccination; mRNA-1273; BNT162b2; tozinameran; dialysis patients; kidney transplant recipients; medical personnel; humoral and cellular immune response; clinical decision-making; guidelines; COVID-19; RECIPIENTS; SPIKE;

D O I：

10.1016/j.lanepe.2021.100178

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

Background: Dialysis and kidney transplant patients are vulnerable populations for COVID-19 related disease and mortality. Methods: We conducted a prospective study exploring the eight week time course of specific cellular (interferon-g release assay and flow cytometry) or/and humoral immune responses (ELISA) to SARS-CoV-2 boost vaccination in more than 3100 participants including medical personnel, dialysis patients and kidney transplant recipients using mRNA vaccines BNT162b2 or mRNA-1273. Results: SARS-CoV-2-vaccination induced seroconversion efficacy in dialysis patients was similar to medical personnel (> 95%), but markedly impaired in kidney transplant recipients (42%). T-cellular immunity largely mimicked humoral results. Major risk factors of seroconversion failure were immunosuppressive drug number and type (belatacept, MMF-MPA, calcineurin-inhibitors) as well as vaccine type (BNT162b2 mRNA). Seroconversion rates induced by mRNA-1273 compared to BNT162b2 vaccine were 97% to 88% (p < 0.001) in dialysis and 49% to 26% in transplant patients, respectively. Specific IgG directed against the new binding domain of the spike protein (RDB) were significantly higher in dialysis patients vaccinated by mRNA-1273 (95%) compared to BNT162b2 (85%, p < 0.001). Vaccination appeared safe and highly effective demonstrating an almost complete lack of symptomatic COVID-19 disease after boost vaccination as well as ceased disease incidences during third pandemic wave in dialysis patients. Conclusion: Dialysis patients exhibit a remarkably high seroconversion rate of 95% after boost vaccination, while humoral response is impaired in the majority of transplant recipients. Immunosuppressive drug number and type as well as vaccine type (BNT162b2) are major determinants of seroconversion failure in both dialysis and transplant patients suggesting immune monitoring and adaption of vaccination protocols. (C) 2021 The Authors. Published by Elsevier Ltd.

引用

页数：11

共 50 条

[21] Humoral and cellular immune response to SARS-CoV-2 mRNA BNT162b2 vaccine in pediatric kidney transplant recipients compared with dialysis patients and healthy children
Ruveyda Gulmez
Dogukan Ozbey
Ayse Agbas
Bagdagul Aksu
Nurdan Yildiz
Diana Uckardes
Seha Saygili
Esra Karabag Yilmaz
Zeynep Yuruk Yildirim
Mehmet Tasdemir
Ayca Kiykim
Haluk Cokugras
Nur Canpolat
Ahmet Nayir
Bekir Kocazeybek
Salim Caliskan
Pediatric Nephrology, 2023, 38 : 2199 - 2208
[22] Trajectory of IgG to SARS-CoV-2 After Vaccination With BNT162b2 or mRNA-1273 in an Employee Cohort and Comparison With Natural Infection
Keshavarz, Behnam
Richards, Nathan E.
Workman, Lisa J.
Patel, Jaimin
Muehling, Lyndsey M.
Canderan, Glenda
Murphy, Deborah D.
Brovero, Savannah G.
Ailsworth, Samuel M.
Eschenbacher, Will H.
McGowan, Emily C.
Mann, Barbara J.
Nelson, Michael R.
Kadl, Alexandra
Woodfolk, Judith A.
Platts-Mills, Thomas A. E.
Wilson, Jeffrey M.
FRONTIERS IN IMMUNOLOGY, 2022, 13
[23] NVX-CoV2373-induced cellular and humoral immunity towards parental SARS-CoV-2 and VOCs compared to BNT162b2 and mRNA-1273-regimens
Hielscher, Franziska
Schmidt, Tina
Klemis, Verena
Wilhelm, Alexander
Marx, Stefanie
Abu -Omar, Amina
Ziegler, Laura
Guckelmus, Candida
Urschel, Rebecca
Sester, Urban
Widera, Marek
Sester, Martina
JOURNAL OF CLINICAL VIROLOGY, 2022, 157
[24] Heterologous immunization with BNT162b2 followed by mRNA-1273 in dialysis patients: seroconversion and presence of neutralizing antibodies
Kohmer, Niko
Rabenau, Holger F.
Ciesek, Sandra
Kraemer, Bernhard K.
Goettmann, Uwe
Keller, Christine
Rose, Daniela
Blume, Carsten
Thomas, Michael
Lammert, Alexander
Lammert, Anne
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 (06) : 1132 - 1139
[25] Humoral Response to BNT162b2 mRNA SARS-CoV-2 Vaccine in Patients with Nondialysis Chronic Kidney Disease
Kervella, Delphine
Braud, Pierre
Garandeau, Claire
Phelizot, Celine
Ambrosi, Xavier
Blancho, Gilles
Hourmant, Maryvonne
Figueres, Lucile
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 16 (12): : 1872 - 1874
[26] Humoral Response of Renal Transplant Recipients to the BNT162b2 SARS-CoV-2 mRNA Vaccine Using Both RBD IgG and Neutralizing Antibodies
Hod, Tammy
Ben-David, Aharon
Olmer, Liraz
Levy, Itzchak
Ghinea, Ronen
Mor, Eytan
Lustig, Yaniv
Rahav, Galia
TRANSPLANTATION, 2021, 105 (11) : E234 - E243
[27] SARS-CoV-2 IgG Spike antibody levels and avidity in natural infection or following vaccination with mRNA-1273 or BNT162b2 vaccines
Hickey, Thomas E.
Kemp, Troy J.
Bullock, Jimmie
Bouk, Aaron
Metz, Jordan
Neish, Abigail
Cherry, James
Lowy, Douglas R.
Pinto, Ligia A.
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (02)
[28] Antibody response to BNT162b2 SARS-CoV-2 mRNA vaccine in adult patients with systemic sclerosis
Chiara Pellicano
Roberta Campagna
Alessandra Oliva
Giorgia Leodori
Marzia Miglionico
Amalia Colalillo
Ivano Mezzaroma
Claudio Maria Mastroianni
Ombretta Turriziani
Edoardo Rosato
Clinical Rheumatology, 2022, 41 : 2755 - 2763
[29] Antibody response to BNT162b2 SARS-CoV-2 mRNA vaccine in adult patients with systemic sclerosis
Pellicano, Chiara
Campagna, Roberta
Oliva, Alessandra
Leodori, Giorgia
Miglionico, Marzia
Colalillo, Amalia
Mezzaroma, Ivano
Mastroianni, Claudio Maria
Turriziani, Ombretta
Rosato, Edoardo
CLINICAL RHEUMATOLOGY, 2022, 41 (09) : 2755 - 2763
[30] Evaluation of Immunogenicity to Three Doses of the SARS-CoV-2 BNT162b2 mRNA Vaccine in Lung Transplant Patients
Guardiani, Mariasilvia
Zingaropoli, Maria Antonella
Dezza, Francesco Cogliati
Centofanti, Anastasia
Carillo, Carolina
Tortellini, Eeva
Dominelli, Federica
Napoli, Anna
Del Borgo, Cosmo
Gaeta, Aurelia
Venuta, Federico
Vullo, Vincenzo
Lichtner, Miriam
Ciardi, Maria Rosa
Mastroianni, Claudio Maria
Russo, Gianluca
VACCINES, 2022, 10 (10)

← 1 2 3 4 5 →